Lagares et al. [13] discovered that TP53TG1 had a tumor-suppressor activity, and the epigenetic inactivation of TP53TG1 abated the transcriptional suppression of YBX1-targeted growth-promoting genes and contributed to the generation of chemoresistance in tumors. The gene discussed is YBX1; the disease is neoplasm.